Imeik Technology Development Co.,Ltd.
300896
Rang in Aktien
#3909
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Aktienkurs
$14.32
Marktkapitalisierung
$4.33B
Veränderung (1 Tag)
3.66%
Veränderung (1 Jahr)
-38.98%
Land
CN
Handel Imeik Technology Development Co.,Ltd. (300896)
Kategorie
Healthcare
EPS für Imeik Technology Development Co.,Ltd. (300896)
EPS zum June 2026 TTM: $0.53
Laut den aktuellen Finanzberichten und dem Aktienkurs von Imeik Technology Development Co.,Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $0.53. Am Ende des Jahres 2023 betrug das EPS $0.87 eine Steigerung gegenüber dem EPS von 2022, das $0.60 betrug.
EPS-Verlauf von Imeik Technology Development Co.,Ltd. von 2014 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.53 | -40.73% |
| 2024 | $0.89 | 2.66% |
| 2023 | $0.87 | 43.49% |
| 2022 | $0.60 | 21.58% |
| 2021 | $0.50 | 60.03% |
| 2020 | $0.31 | 60.24% |
| 2019 | $0.19 | 75.48% |
| 2018 | $0.11 | 40.94% |
| 2017 | $0.08 | 60.00% |
| 2016 | $0.05 | 189.94% |
| 2015 | $0.02 | -41.92% |
| 2014 | $0.03 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $8.85 | 1,577.73% |
US
|
|
| $6.41 | 1,114.26% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 529.38% |
US
|
|
| - | - |
CH
|
